August 22, 2013
3 min read
Save

Study: Research supports less aggressive treatment for pediatric upper extremity fractures

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

An analysis of research presented at the Pediatric Orthopaedic Society of North America and the American Academy of Orthopaedic Surgeons across 2 decades revealed recommendations for less aggressive treatments of pediatric upper extremity fractures, despite a trend toward more operative treatments.

“Even though clinical research has consistently favored less aggressive treatments over the past 20 years, it has not altered the trend toward more operative treatments,” Emily A. Eismann, MS, and colleagues wrote in the study. “This divergence between research and practice must be explored in our efforts to improve the quality, safety and value of the care that we provide to our pediatric patients.”

Eismann and colleagues analyzed the abstracts from the two annual meetings from 1993 until 2012, taking note of presentations that were more aggressive, less aggressive or neutral through an analysis by two surgeons, according to the abstract. Using Spearman correlations, the researchers examined differences in levels of evidence, treatment recommendations and fracture location.

Researchers found 47% of abstracts suggested less aggressive treatment, while 27% of abstracts recommended neutral action, according to the abstract. More aggressive treatment was recommended in 24% of studies with operative treatment and 11% of studies with nonoperative treatment.

Case studies recommended aggressive treatment more often than comparative studies, and studies with fewer patients recommended aggressive treatment more often than studies with a larger patient group. Overall, 91% of level I and level II, 81% of level III and 70% of level IV studies recommended less aggressive or neutral treatments, according to the abstract.

Disclosure: The authors have no relevant financial disclosures.